NL-OMON53281尚未招募不适用
Researching trained immunity in SLE patients - TACTIC-SLE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age between 18 and 70 years old.
- •Positive SLE diagnosis.
排除标准
- •Lack of informed consent
- •Current infection
- •CKD stage 5 or dialysis
- •Active cancer
研究者
相似试验
已完成
2 期
A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease StateSystemic Lupus Erythematosus (SLE)NCT04451772AbbVie185
进行中（未招募）
2 期
Centrally Acting ACE Inhibition in SLESystemic Lupus ErythematosusNCT04486118Northwell Health36
进行中（未招募）
4 期
Immune Cell Subsets in SLE Patients Treated with TelitaciceptSystemic Lupus Erythematosus (SLE)NCT06677801Second Affiliated Hospital, School of Medicine, Zhejiang University50
已完成
2 期
Low-dose Interleukin-2 for Treatment of Systemic Lupus ErythematosusLupus Erythematosus, SystemicNCT03312335Onur Boyman, MD16
已完成
1 期
Omalizumab for LupusSystemic Lupus ErthematosusSjogren's SyndromeNCT01716312National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)17